Cost-Utility Analysis of IEV Drug Regimen Versus ESHAP Drug Regimen for the Patients With Relapsed and Refractory Hodgkin and Non-Hodgkin's Lymphoma in Iran.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Mehdi Dehghani Nahid Hatam |
| Publication date | October 27, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |